EQ Resources shares (ASX: EQR) surged to the top of the ASX 200 on Tuesday after signing a binding framework agreement to restart a major U.S. tungsten processing plant, backed by the American Department of War.
The EQR share price heads into today’s session off the back of an 11.69% gain to A$0.43 on Tuesday, with an intraday high of A$0.46 that matched the stock’s all-time high close from 2007, a level not revisited in nearly two decades.
EQR has now added 437.5% since the turn of 2026, as the company has progressively repositioned itself from a regional tungsten miner operating in Australia and Spain into what is shaping up as an integrated participant in the Western world’s critical minerals supply chain.
A Closer Look At The Deal
The catalyst was the execution of a binding framework agreement between EQR, U.S.-listed advanced components manufacturer The Elmet Group (NASDAQ: ELMT), and Canadian-listed Blue Moon Metals (TSXV: MOON; NASDAQ: BMM) to restart, own, and operate the Springer ammonium paratungstate (APT) processing plant in Nevada.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
The plant, which carries a nameplate capacity of 4,000 tonnes per annum, would produce APT, the refined intermediate product derived from tungsten ore concentrates that sits at the heart of industrial and defense-grade tungsten supply chains.
Ownership of the joint venture breaks down with The Elmet Group holding a 70% interest and will act as operator; Blue Moon Metals holds 20% and contributes the existing plant infrastructure, land, and full concentrate offtake from its adjacent Springer Mine; and EQR holds a 10% interest, entitling the company to one nominee director on a seven-member board.
The capital structure is notably favourable for EQR, with Elmet is responsible for funding the first US$75 million of restart expenditure, with EQR’s additional cost exposure capped at US$3.125 million for expenditures falling between US$75 million and US$100 million. Should total costs exceed US$100 million, remaining expenditure would be split pro-rata among the partners according to their respective equity interests. This structure limits EQR’s maximum near-term cash commitment to a manageable figure relative to the scale of the asset being developed.
Commercial terms secured by EQR are equally important. The company has locked in an eight-year, spot-priced offtake agreement under which the joint venture will purchase 4,000 tonnes of contained tungsten trioxide (WO3) in concentrate from EQR, with deliveries nominally commencing at 500 tonnes per annum from plant commissioning and extendable by mutual agreement. EQR also gains guaranteed access to 1,000 tonnes per annum of APT processing capacity, representing 25% of Phase 1 capacity, for the first five years of operations. Additionally, EQR’s proprietary ore-sorting technology may be licensed to Blue Moon Metals as part of the broader commercial arrangement.
What Lay Ahead
The Springer APT plant restart is targeted for the second half of 2028, with Blue Moon’s Springer Mine expected to reach production around the fourth quarter of 2027. That means the commercial benefits of the JV remain multi-year milestones rather than near-term earnings contributors.
From a technical standpoint, the stock’s intraday test of A$0.46 represents a significant psychological and historical resistance level. A sustained break above that level on strong volume would likely attract fresh momentum-driven interest, while a failure to hold current levels after a 437.5% year-to-date run could invite profit-taking from earlier-positioned holders.
The key risks to monitor are the progression from binding framework to definitive agreements, the pace of capital deployment by Elmet, and the broader trajectory of U.S. defense spending and critical mineral policy.
Bull Case:
- Capital-light 10% JV stake secured with maximum near-term cash exposure of just US$3.125 million.
- Eight-year spot-priced offtake embeds EQR’s Australian and Spanish output into U.S. defense supply chains.
- US$450 million Department of War backing substantially de-risks Springer restart capital formation.
- Proprietary ore-sorting technology licence adds a low-cost, high-value revenue stream.
- Regulatory permits and NEPA clearance already secured, reducing development timeline risk.
Bear Case:
- Framework agreement still subject to final definitive agreements and closing conditions.
- Plant commissioning targeted for 2H 2028, delaying meaningful cash flow contribution significantly.
- A 437.5% YTD gain leaves the stock highly vulnerable to profit-taking or sentiment shifts.
- Pro-rata cost exposure above US$100 million could strain EQR’s balance sheet if overruns materialise.
- Long-term value depends on sustained U.S. defense spending and stable tungsten policy priorities.
